Privi Speciality Chemicals Intrinsic Value
PRIVISCL • Chemicals
Current Stock Price
₹2938.20
Primary Intrinsic Value
₹1153.92
Market Cap
₹114.6K Cr
-70.0%
Downside
Median Value
₹881.46
Value Range
₹588 - ₹1477
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%
PRIVISCL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1153.92 | ₹923.14 - ₹1384.70 | -60.7% | EPS: ₹96.16, Sector P/E: 12x |
| Book Value Method | asset | ₹587.64 | ₹528.88 - ₹646.40 | -80.0% | Book Value/Share: ₹286.67, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹881.46 | ₹793.31 - ₹969.61 | -70.0% | Revenue/Share: ₹696.41, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1175.28 | ₹1057.75 - ₹1292.81 | -60.0% | EBITDA: ₹728.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1175.28 | ₹940.22 - ₹1410.34 | -60.0% | CF Growth: 13.1%, Discount: 15% |
| PEG Ratio Method | growth | ₹881.46 | ₹793.31 - ₹969.61 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹881.46 | ₹793.31 - ₹969.61 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1476.92 | ₹1329.23 - ₹1624.61 | -49.7% | ROE: 32.2%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹881.46 | ₹793.31 - ₹969.61 | -70.0% | EPS: ₹96.16, BVPS: ₹286.67 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
PRIVISCL Intrinsic Value Analysis
What is the intrinsic value of PRIVISCL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Privi Speciality Chemicals (PRIVISCL) is ₹881.46 (median value). With the current market price of ₹2938.20, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹587.64 to ₹1476.92, indicating ₹587.64 - ₹1476.92.
Is PRIVISCL undervalued or overvalued?
Based on our multi-method analysis, Privi Speciality Chemicals (PRIVISCL) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.40 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 32.2% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.97x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Privi Speciality Chemicals
Additional stock information and data for PRIVISCL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹281 Cr | ₹134 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹355 Cr | ₹265 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹49 Cr | ₹-18 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹5 Cr | ₹-156 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹172 Cr | ₹51 Cr | Positive Free Cash Flow | 7/10 |